SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: david cohen who wrote (1106)12/18/1997 11:23:00 PM
From: BigKNY3  Read Replies (1) | Respond to of 7041
 
David << Zona's drug has all the potential to be as big as Pfizers.>>

David: Please support your statement with facts or theory.

If approved, Vasomax may find a niche in the ED market. However, I believe Viagra's market potential is far greater due to the following:

-Viagra will have at least a one year headstart over Vasomax.
- Viagra has shown greater efficacy than Vasomax in Phase III clinical studies.
- Pfizer is considered the best marketing company in Big Pharma.

BigKNY3



To: david cohen who wrote (1106)12/19/1997 1:44:00 PM
From: Jumper  Respond to of 7041
 
INVESTORS BEWARE short hypsters and guest bears are tricky devils.

ZONA is not a scam, it has fallen 10 points because...

THE BIG BOYS ARE ACCUMULATING...THE BIG BOYS WILL ACCUMULATE TO ZERO

These shorts will get what is coming to them...probably another 15 points on the downside IMO but who cares it is only money- wait until you see them squirm through the short squeeze rally from 5 to 7.

:) Jumper